Topics

FDA Clears First Topical Form of Minocycline for Acne

12:44 EDT 21 Oct 2019 | Medscape

Minocycline topical foam (Amzeeq) is for the treatment of inflammatory lesions of nonnodular moderate to severe acne vulgaris in adults and children aged 9 years or older.
FDA Approvals

Original Article: FDA Clears First Topical Form of Minocycline for Acne

NEXT ARTICLE

More From BioPortfolio on "FDA Clears First Topical Form of Minocycline for Acne"

Quick Search

Relevant Topics

Acne
Acne is a common skin condition that causes spots to develop on the skin, usually on the face, back and chest..  The spots can range from blackheads and whiteheads which are often mild, to inflamed pus-filled pustules and cysts, which can be severe ...

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...